Posted on 06/05/2019 10:33:08 AM PDT by RummyChick
One of the world's biggest drug firms deliberately buried data showing one of its arthritis medications could slash the risk of Alzheimer's.
Pfizer kept its finding under wraps for more than three years because, it claims, it didn't believe the evidence was strong enough.
It found the link between Alzheimer's and the drug Enbrel when analysing medical insurance claims in hundreds of thousands of people in the US.
People taking Enbrel, an anti-inflammatory used to treat rheumatoid arthritis, appeared to be 64 per cent less likely to develop the memory-robbing disorder.
(Excerpt) Read more at dailymail.co.uk ...
Yes
Why would a drug company hide a poten market
Agreed - they would have another Viagra (which was originally for heart conditions) on their hands if this is true. I suspect that they might be investigating this but it’s under the correlation is not causation category.
Exactly. There's more going on here.
If they could get the drug labeled for use in treating Alzheimer's (in addition to RA), their sales would increase. Why would a drug company hold back on that is that was the only issue in play?
The patent running out must have been a crucial factor in this.
I think I agree with Pfizer here.
Any company would jump at a chance to make billions off of a working Alzheimer’s drug.
There’ve been several widely publicized drugs that hit the market for testing that promptly failed (and hurt the company financially in the process) that Pfizer taking a conservative approach may have been prudent.
Drug companies are not interested in prevention, that’s why. Do they have another drug under development or on the shelves for Alzheimers?
Note the date...
!UW.yye1fxo
>>> 7 Feb 2018 - 10:06:12 PM <<<
What if cures already exist?
What about the billions (public/private/govt) provided to fund cure dev?
It is very simple.
If they would have said anything, the FDA would have forbidden them to make such claims.
Just looked at the cost of Enbrel. WOW. not sure how long that $5,000 dose lasts
Remember, the media love salacious headlines - EVIL DRUG COMPANY DOES XXX
The US FDA would come down on Pfizer ike a ton of bricks if they claimed their drug treated an “unrelated” disease. Liability potential would be outrageous also. They certainly would NOT be allowed to market the drug for Alzheimers unless years of studies were conducted.
I don’t like taking drugs and try to stay off them. But I might rethink it it since I could probably qualify due to a psoriasis patch on my leg.
Probably just an indicator that they are working with the government to contaminate the water supply with inflammatories thereby causing Alzheimer’s in selected populations. Apparently dumbing down the education system is not doing enough for the central planners’ taste.
Possibilities
More likely there was some indication but test trials would have been so expensive they wouldn’t recover the cost.
At Intel, we abandoned many designs as analysis said little return on investment.
We had several designs in the works which were trending so badly, we just said “no more”
Doing absolutely nothing until the patent for Embrel ran out means they've given up whatever advantage they would have had to develop a new drug first.
Doesn't make sense.
Not the issue. This is not about them making the claim to market the item.
This is about doing clinical trials.
I think the patent ran out before the trials would be over. 2015. 4 years. Patent ran out in 2018.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.